GLAUKOS Corp

GKOS NYSE CIK: 0001192448

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1 GLAUKOS WAY, ALISO VIEJO, CA, 92656
Mailing Address 1 GLAUKOS WAY, ALISO VIEJO, CA, 92656
Phone 949-367-9600
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

-$134.66M
Net Income
$766.93M
Stockholders' Equity
$-2.77
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report April 2, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC

Annual Reports

10-K February 23, 2026
  • GLAUKOS reported $325 million in revenue, an 18% increase, and achieved a net income of $15 million, a significant turnaround from a prior year loss.
  • The company strategically acquired Mobius Therapeutics LLC, bolstering its corneal health pipeline, and launched a new state-of-the-art manufacturing facility.
View Analysis

Insider Trading

STRONG SELL 7 insiders 23 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.